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ABSTRACT 
The early life environment is a crucial time for establishing the trajectory of future 
health. Low birthweight is considered a marker of an adverse in utero 
environment and predisposes to cardio-metabolic disease later in life. It has 
been proposed that this is mediated by glucocorticoids, with life-long 
activation of the HPA axis. Here we review the evidence to support this 
hypothesis, with particular emphasis on the effects of fetal growth and 
nutrient stresses in utero on steroid pathways of the HPA axis. A better 
understanding of the mechanisms underlying these processes could help to 
optimize in utero health, and identify individuals at greatest risk of future 
disease.  
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1. INTRODUCTION 
The early life environment is established as a crucial time for influencing the 
trajectory of future health. Epidemiological studies reported in the past two decades 
have highlighted the importance of fetal adaptations to a poor intrauterine 
environment for longer-term health outcomes[1, 2]. A growing body of evidence has 
shown associations between low birthweight, a surrogate marker of an adverse 
intrauterine environment and subsequent cardio-metabolic disease, and mental 
health problems. This concept is termed ‘early life programming’ or the 
‘developmental origins of health and disease’ hypothesis[3]. The developing fetus is 
thought to respond to insults in utero with adaptations in structure, physiology and 
metabolism. Although these adaptations may initially be beneficial, later in life they 
may become maladaptive and predispose to disease.  
 
One mechanism proposed for these adaptations, is a ‘programming’ of the offspring 
hypothalamic-pituitary-adrenal (HPA) axis in utero. The HPA axis is highly 
susceptible to programming during fetal and neonatal development[4]. The ability of 
the early environment to modify HPA development and subsequent function was first 
described over 40 years ago[5]. However, recent epidemiological evidence indicating 
that the fetal environment can profoundly influence disease processes later in life[6] 
has rejuvenated research in the field. Robust correlations between birth weight, 
plasma cortisol concentrations and the development of hypertension and type 2 
diabetes have been identified[7-9]. Changes in the HPA axis are also postulated to 
underlie some of the programmed changes that may occur, secondary to nutrient 
stresses, such under or over nutrition, or secondary to maternal stress. In this review, 
we focus on the evidence from human studies linking fetal growth and in utero 
stresses on the steroid pathways of the offspring HPA axis, and the implications this 
may have for health later in life.  
 
 
2. THE HPA AXIS AND ITS CHANGES DURING PREGNANCY 
Glucocorticoids are vital for life, acting upon and influencing virtually all tissues and 
physiological functions. These include metabolism, blood pressure, fluid and 
electrolyte homeostasis and the immune system. They also mediate increasing 
energy demands in response to stress. In response to both physiological and 
psychological stress, cortisol is secreted by the adrenal gland, which is regulated by 
the HPA axis. The release of cortisol follows a circadian rhythm, which is 
characterized by peak levels of cortisol prior to activity in the morning and a 
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subsequent decline throughout the rest of the day. Circadian release of 
adrenocorticotrophic hormone (ACTH) from the pituitary is stimulated by the action of 
corticotrophin releasing hormone (CRH) and vasopressin (AVP) from the 
hypothalamus, under control of the hypothalamus. This circadian rhythm of cortisol 
release can be interrupted by stressors, which cause a premature release of 
glucocorticoids. Cortisol release also follows a pulsatile fashion, with an ultradian 
rhythm of hormone oscillations. These oscillations are thought to be important for 
optimal transcriptional regulation[10]. Circulating glucocorticoids are predominantly 
protein bound[11] to corticosteroid binding globulin (CBG). At high physiological 
levels, binding proteins are saturated which allows greater diurnal fluctuation in levels 
of free, bioavailable cortisol.  
 
Glucocorticoids are also required for normal fetal growth and development. A number 
of endocrine changes occur during pregnancy, causing a dramatic activation of the 
maternal HPA axis. As a result of this, maternal cortisol levels increase 
exponentially[12, 13]. The placenta, which has significant endocrine properties, 
secretes CRH from the second trimester onwards, and this activates the maternal 
HPA axis to stimulate cortisol production (figure 1). A complex feed-forward loop is 
created, with cortisol also stimulating placental CRH synthesis[13, 14]. The placenta 
also secretes estrogen and progesterone, both of which may mediate levels of free, 
bioavailable cortisol[14, 15]. Estrogen stimulates the hepatic synthesis of CBG during 
pregnancy[16]. Progesterone has also been shown to displace cortisol from 
CBG[15].  
 
The circadian rhythm of cortisol release is maintained during pregnancy[17], but as 
gestation advances, the cortisol awakening response and normal physiological 
responses to stressors (both markers of basal HPA activity) are attenuated[13]. 
Glucocorticoids are lipophilic, and can therefore freely cross the placenta from the 
maternal to the fetal compartments, and levels of maternal cortisol are therefore 
thought to influence fetal cortisol levels. Maternal plasma cortisol has been shown to 
be a significant predictor of amniotic fluid cortisol, independent of maternal age, 
gestation age and time of collection[18]. A pattern of increasing positive correlation 
between maternal plasma and amniotic fluid cortisol with increasing gestation has 
also been reported[18-21].  
 
Fetal glucocorticoid levels are up to 10-fold lower than maternal levels, due to the 
actions of placental 11-beta-hydroxysteroid dehydrogenase type 2 (11β-HSD2); an 
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enzyme-based barrier that deactivates active cortisol into inactive cortisone[22]. 
Levels of 11β-HSD2 in the human placenta increase with advancing gestation[23], 
thus limiting fetal glucocorticoid exposure during critical stages of development 
during pregnancy. However, this barrier is not complete as up to 20% of maternal 
glucocorticoids cross to the fetal compartment[24]. Although the regulation of 11β-
HSD2 is not fully understood, both human and animal studies have suggested that 
the efficiency of placental 11β-HSD2 varies considerably, and may be weakened by 
diet, infection, inflammation, hypoxia and stress. Reduced efficiency of this enzyme 
would therefore allow a greater transplacental passage of cortisol to the developing 
fetus[25, 26]. Given that maternal cortisol levels are considerably higher than fetal 
levels, even modest changes in placental 11B-HSD2 activity can significantly alter 
fetal glucocorticoid exposure[20, 27]. 
 
Glucocorticoids bind to glucocorticoid and mineralocorticoid receptors[28]. These 
receptors are activated upon ligand binding and the receptor-ligand complex 
translocates to the nucleus, where it binds to glucocorticoid response elements in the 
promoter region of target genes, and can then influence gene transcription. 
Glucocorticoids can also exert non-genomic effects by direct actions on membrane 
lipid and cytoplasmic proteins via membrane-located receptors[29]. Glucocorticoid 
receptor (GR) is expressed from mid-gestation onwards in fetal tissues, the placenta 
and fetal membranes[30]; and mineralocorticoid receptor (MR) is more limited and 
tends to be present later in gestation[31].  
 
Glucocorticoids play a key role in organ maturation to prepare the fetus for extra-
uterine life, and the rise in maternal cortisol levels in later gestation parallels the 
increasing maturity of fetal organs[32]. This is also the rationale for administering 
synthetic glucocorticoids to women who are suspected to deliver at preterm 
gestations, to accelerate fetal lung maturation and reduce the risk of respiratory 
complications for the premature neonate[33]. 
 
 
3. FETAL GROWTH 
a. Glucocorticoid overexposure in utero is associated with lower birthweight 
In addition to promoting maturation of fetal organs, increased cortisol levels may 
increase availability of glucose for the developing fetus, by mobilizing substrates for 
hepatic gluconeogenesis[34]. This premise would suggest that increased fetal 
glucocorticoid exposure might lead to increased fetal growth. However, contrary to 
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this suggestion both human and animal studies indicate that although glucocorticoids 
are crucial for normal growth and development, a fine balance of fetal glucocorticoid 
exposure is required, as fetal over-exposure to glucocorticoids is in fact linked with 
fetal growth restriction[35], and recently, epidemiological studies have also linked the 
association with increased cardiovascular risk later in life[36, 37]. Timing of fetal 
glucocorticoid exposure also appears critical, as for example, amniotic fluid cortisol 
levels (a surrogate marker for fetal glucocorticoid exposure) measured at 15-18 
weeks are negatively correlated with birthweight (r=-0.25, P<0.01) and gestational 
age (r=-0.18, p<0.05)[19], suggesting that cortisol levels in the second trimester of 
pregnancy may influence fetal growth.  
 
Maternal cortisol levels have also been shown to predict offspring birthweight. In a 
large cohort (n=28,010), high maternal total serum cortisol at 20 weeks gestation was 
negatively associated with offspring birthweight (β=-0.35; p<0.01), and was positively 
associated with risk for ‘small for gestational age’ (SGA) (Odds ratio [OR]=1.00; 
p=0.027), although blood samples were obtained at different times of day, and 
significance was lost after controlling for covariates[38]. This pattern of a negative 
correlation with birthweight has also been observed in maternal saliva samples, 
which are reflective of free cortisol levels. A smaller study of 70 pregnant women 
found that even after adjusting for covariates, that mothers with a higher salivary 
cortisol awakening response at 13-18 weeks gestation had babies of lower 
birthweight who were also shorter at birth[39]. In this study, morning cortisol levels 
explained 19.8% of the variance in birth weight and 9% of the variance in body 
length[39]. Another small study of 98 women[40], showed that maternal saliva 
cortisol at 36 weeks found that that both morning cortisol and a steeper morning 
decline were associated with lower birthweight. The heaviest neonates were born to 
women with a relatively flat diurnal rhythm characterized by a blunted morning 
peak[40]. Taken together, these studies suggest that a flattening of the diurnal 
rhythm of cortisol secretion may protect the fetus from overexposure to 
glucocorticoids during the morning peak.  
 
 
b. Fetal glucocorticoid overexposure and low birthweight are associated with 
increased activity of the HPA axis 
In human studies altered glucocorticoid exposure in utero is associated with 
increased activity of the offspring HPA axis. For example, higher maternal cortisol 
levels in mid-late gestation are associated with increased cortisol response in the 
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newborn to the stress of a heel prick test[41]. This study suggests the window of 
susceptibility of the fetal HPA axis to excess maternal glucocorticoids is in mid-late 
gestation. By 24 weeks gestation, both GR and MR are present in the human 
hippocampus, which is an important site for glucocorticoid central negative 
feedback[42]. Animal studies have shown that excessive glucocorticoids can alter the 
density of these receptors in both the hippocampus and amygdala, with 
consequences for HPA axis feedback sensitivity[43, 44]. Thus, cortisol exposure in 
late pregnancy may influence the neonatal HPA axis response. Consistent with this 
is the observation that lower maternal cortisol levels, particularly in the third trimester, 
in women with post traumatic stress disorder, which itself is associated with low 
cortisol, are associated with lower cortisol levels at awakening and bed-time in their 
offspring at aged 1 year[45]. 
 
Observational studies of women who consume large amounts of licorice during 
pregnancy (which contains glycyrrhizin, and 11β-HSD2 inhibitor)[46] also serve as 
proof of concept that 11β-HSD2 is relevant for fetal glucocorticoid exposure, and 
subsequent fetal outcome. These studies found that although high licorice 
consumption during pregnancy did not significantly affect birthweight, there was 
evidence of earlier gestation at delivery and altered HPA axis function of the 
offspring. At aged 8 years, offspring of women with high licorice consumption during 
pregnancy had raised fasting cortisol levels, and an increased cortisol secretion in 
response to psychological stress, compared to the offspring of women with lower 
licorice consumption[46]. In utero licorice exposure was also associated with 
significant increases in externalizing symptoms, attention, rule breaking and 
aggression problems with notably a 2.26 fold increase in attention deficit 
hyperactivity disorder, which may be mediated by altered glucocorticoid exposure in 
utero[47]. 
 
There is also evidence that changes in offspring HPA axis activity associated with 
low birthweight may also persist across the lifespan. Low birthweight is associated 
with increased fasting cortisol concentrations in populations of men and women 
ranging from young adulthood to older life[7, 9, 48]. A meta-analysis of 11 studies 
including data from fasting cortisol measurements from 2301 subjects reported that 
cortisol concentrations fell on average by 25.3nmol/kg increase in birthweight[9]. The 
measurement of fasting cortisol is itself considered a ‘stress’ response due to the 
reaction to venepuncture, particularly in the context of attending a research clinic in 
an unfamiliar situation after an overnight fast. This argument has been used to 
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explain the lack of association between cortisol and birthweight in adult studies 
reporting integrated cortisol exposure over the day[49-51]. However studies 
measuring cortisol when stimulated by ACTH, or in response to psychological stress 
suggest that the response of the HPA axis is susceptible to fetal programming[7, 52-
57]. Salivary cortisol responses to the psychological stress of the ‘Trier Psychosocial 
Stress Test’ (TSST) in 106 male twins at age 18 years were significantly and 
inversely related to the subjects’ birthweight, and the low birthweight twins had higher 
salivary cortisol levels in response to the stress[56]. Dynamic function studies of the 
HPA axis have demonstrated that lower birthweight was associated with increased 
responsiveness to synthetic ACTH, which is strongly suggestive of increased 
activation of the HPA axis[52-54]. In accord with this, children, adolescents and 
adults with lower birthweight have been reported to excrete more cortisol and its 
metabolites in urine[53, 58, 59]. There is currently no evidence that the association 
between high fasting cortisol and low birthweight is explained by altered central 
negative feedback sensitivity of the HPA axis. Studies using dexamethasone 
suppression, which tests the GR component of central negative feedback, found no 
differences in the central negative feedback sensitivity in association with 
birthweight[53, 54]. However, further tests of the contribution of both MR and GR 
demonstrated altered central negative feedback sensitivity in obesity[60]. Similar 
studies are required to test whether this also occurs in association with low 
birthweight. Taken together, these studies suggest that the HPA axis response to 
stress may be susceptible to fetal programming, and that the resultant increased 
HPA axis activity persists into adult life. Importantly raised fasting and ACTH 
stimulated cortisol levels are associated not only with low birthweight, but also with 
an adverse metabolic profile[7, 48, 53, 54]. This supports the hypothesis that fetal 
programming could result in long-term changes in cortisol secretion, which in turn 
could lead to increased glucocorticoid exposure over a lifespan, and a predisposition 
to cardio-metabolic disease later in life.  
 
 
4. FACTORS INFLUENCING FETAL GLUCOCORTICOID EXPOSURE  
A number of factors have been proposed to alter fetal glucocorticoid exposure, 
including maternal stress, maternal diet and nutrient stresses. 
 
a. Maternal stress may alter fetal glucocorticoid exposure 
It is well established that prenatal stress is associated with low birthweight [61, 62] 
and it has been suggested that this may be due to increased fetal glucocorticoid 
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exposure, as a result of altered circulating levels of maternal cortisol associated with 
stress and anxiety during pregnancy and/or changes in placental gene expression. 
However, the data are inconsistent as while some studies report increased cortisol 
levels when mothers experience higher levels of stress[63] or anxiety[18, 21], others 
found no such findings[64, 65]. There is also some evidence that exposure to stress 
in utero may also program the offspring HPA axis[66-69]. One potential mechanism 
proposed for this is alteration of placental biology (figure 2). In late pregnancy, 
maternal anxiety is associated with down regulation of 11β-HSD2 mRNA 
expression[70], which may increase fetal glucocorticoid exposure; and maternal 
depression is associated with increased mRNA expression of GR and MR, which 
may increase placental glucocorticoid sensitivity[71]. Further, there is some evidence 
that prenatal exposure to maternal depression is associated with increased DNA 
methylation of the GR (NR3C1), which suggests that there may be a potential 
epigenetic process that links antenatal maternal mood and HPA stress reactivity[72].  
Maternal plasma and amniotic fluid cortisol measurements have shown that 
correlation coefficients between maternal and amniotic fluid cortisol increased with 
increasing maternal anxiety scores, suggesting that maternal anxiety may reduce the 
efficiency of placental 11β-HSD2[18], which has also been shown to occur after 
prenatal stress in animal studies[73]. Consistent with this, urine morning cortisol at 
20 weeks in 300 depressed women found that higher maternal urinary cortisol was 
associated with lower birthweight in the offspring, and a higher incidence of 
prematurity[74]. Prenatal stress is also associated with an altered circadian rhythm of 
cortisol, with children exposed to in utero stress with high morning cortisol levels and 
then flattening of the day curve[75, 76]. Infants of mothers with symptoms of 
depression have been noted to have higher urinary cortisol within the first week of 
life, consistent with overall increased HPA axis activity[77].  
 
b. Maternal diet and nutrient stresses may alter fetal glucocorticoid exposure  
In animal models altered fetal glucocorticoid exposure has been proposed as one 
mechanism linking the robust observations of changes in maternal diet during 
pregnancy with adverse programmed offspring outcomes including lower 
birthweight[78], raised blood pressure[79, 80] and reduced lifespan[81-89]. For 
example, maternal malnutrition may cause a stress response in the mother and the 
fetus[78, 90], and increased stress may simultaneously limit food intake[90]. In 
humans, epidemiological evidence suggests that intrauterine experience of maternal 
undernutrition plays a major role in the aetiology of cardiovascular diseases[91] and 
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developmental programming[92], but in these studies it is harder to dissect effects of 
maternal diet per se on outcome from other potential confounders. 
 
Further it is challenging to study the effects of malnutrition during human pregnancy, 
as this is often not restricted to pregnancy alone. The Dutch famine has provided the 
opportunity to study the long-term health effects for offspring of women exposed to 
malnutrition at different stages in pregnancy. In this cohort, there were increased 
rates of coronary heart disease in those exposed to famine in utero, and those 
exposed in later gestation had decreased glucose tolerance[93]. People exposed to 
malnutrition in early gestation had higher systolic blood pressure responses to 
stress[94], but no changes in HPA axis responses to stress, ACTH stimulation or 
psychological stress were documented in relation to prenatal famine exposure at any 
stage in pregnancy[95, 96]. The authors argued that although there was no evidence 
of fetal programming at the adrenal level, it is possible that the HPA axis may be 
altered at the level of the hippocampus or hypothalamus, which has been observed 
in studies of rats subjected to malnutrition during pregnancy[86, 97]. However, these 
findings may also suggest that prenatal exposure to famine linked to fetal 
programming of the autonomic nervous system, and that this is more important the 
HPA axis in terms of increasing susceptibility of offspring to cardio-metabolic 
disease. The lack of response of the HPA axis in response to famine also contrasts 
with observations of higher cortisol secretion in response to psychological stress in 
adult offspring of women who consumed an unbalanced diet during late pregnancy 
[98]. This supports the notion that nutrient stressors in utero can program the 
offspring HPA axis. 
 
Maternal obesity and in utero exposure to overnutrition 
At present the effects of over-nutrition during human pregnancy on the offspring HPA 
axis are not known. Obesity in non-pregnancy is associated with dysregulation of the 
HPA axis, notably with activation of the axis but with associated increased hepatic 
metabolism and renal excretion of cortisol, ultimately leading to normal or lower 
levels of circulating cortisol[99-101]. If this dysregulation of the HPA axis is 
maintained during pregnancy, it is possible that the offspring of obese women may 
be exposed to altered glucocorticoid levels, and that this could impact upon fetal size 
and risk of disease later in life. Indeed, maternal obesity is associated with increased 
fetal size[102], and with increased risk of cardiovascular events and premature death 
in adult offspring, compared with offspring of mothers with normal body mass 
index[103]. As up to 35% of women of reproductive age in the United States and 
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Europe are obese[104-106], a better understanding of the effects of maternal over-
nutrition and increased birthweight on offspring HPA axis and subsequent disease 
risk is urgently required. 
 
 
5. CONCLUSIONS 
There is a growing body of evidence to support the hypothesis that fetal 
glucocorticoid overexposure is associated with low birthweight, and may predispose 
to subsequent cardio-metabolic disease, via altering the activity of the HPA axis. 
Exposure to maternal stress and nutrient stresses in utero have the potential to 
impact on maternal HPA axis activity and/or pathways within the placenta regulating 
fetal glucocorticoid exposure.  Whether or not interventions during pregnancy to 
regulate HPA axis activity would be beneficial, is currently unknown, though 
preliminary data suggests use of stress reduction instructions in pregnancy may 
reduce maternal perceived stress as well as morning cortisol levels[107]. Further, 
activity of 11β-HSD2 may itself, be a suitable target for modification. A greater 
understanding of placental metabolism of cortisol, and transport of glucocorticoids 
between the maternal and fetal compartments, may also help identify modifiable 
targets for mediating fetal glucocorticoid exposure.  
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Figure Legends 
 
Figure 1. The Hypothalamic Pituitary Adrenal Axis (HPA) in Pregnancy. Figure 
shows interaction between maternal and placental compartments during pregnancy 
which contribute to an increase in maternal cortisol levels. Placental release of CRH 
drives the maternal HPA axis increasing cortisol production, which further stimulates 
placental CRH release via a positive feed-forward loop. Placental estrogen 
production also stimulates hepatic synthesis of CBG, to which free cortisol binds.   
ACTH – adrenocorticotropic hormone, CRH – corticotrophin releasing hormone, CBG 
– corticosteroid binding globulin.  
 
Figure 2. Modifications to placental biology that may alter fetal glucocorticoid 
exposure. Altered maternal HPA axis may alter fetal glucocorticoid exposure. 
Maternal stress and nutrient stresses may downregulate placental 11β-HSD2 mRNA 
expression, which may increase transplacental passage of glucocorticoids. Maternal 
depression may increase placental GR and MR mRNA expression, which may 
increase placental sensitivity to glucocorticoids. All these placental modifications may 
increase fetal glucocorticoid exposure, which is associated with activation of the fetal 
HPA axis. This may predispose to cardio-metabolic disease later in life.  
HPA – hypothalamic pituitary adrenal. mRNA – messenger ribonucleic acid, 11β-
HSD2 – 11beta-hydroxysteroid dehydrogenase, GR – glucocorticoid receptor, MR – 
mineralocorticoid receptor. 
